Stay updated on KSI-301 vs Aflibercept in Wet AMD Clinical Trial
Sign up to get notified when there's something new on the KSI-301 vs Aflibercept in Wet AMD Clinical Trial page.

Latest updates to the KSI-301 vs Aflibercept in Wet AMD Clinical Trial page
- Check3 days agoChange DetectedThe ClinicalTrials.gov footer revision label updates from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error instead of study details.SummaryDifference0.2%

- Check10 days agoChange DetectedA banner announces that NIH is transitioning to use “Super Intelligence” in place of “Artificial Intelligence,” with both terms appearing during the transition.SummaryDifference1%

- Check17 days agoChange DetectedThe footer revision was updated from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check24 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check45 days agoChange DetectedThe page now displays a 403 Forbidden error with the standard site header and footer, indicating the study record is not accessible. The previously visible study content and documents appear to be removed or hidden, leaving only navigation and site chrome.SummaryDifference18%

- Check66 days agoChange DetectedThe page revision label changed from Revision: v3.6.5 to Revision: v3.6.6. This indicates deployment of a newer build of the page.SummaryDifference0.0%

Stay in the know with updates to KSI-301 vs Aflibercept in Wet AMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KSI-301 vs Aflibercept in Wet AMD Clinical Trial page.